Randomized, double-blind, placebo-controlled trial of tirilazad mesylate in subarachnoid hemorrhage: cooperative study in North America

Completed

Phase N/A Results

Summary of Purpose

To assess effects of tirilazad mesylate in treatment of aneurysmal subarachnoid hemorrhage

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 April 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Randomized, double-blind, vehicle-controlled, sequential dose-escalation study of 902 patients at 54 North American neurosurgical centers.

Contacts

Not available